The whipping post

Every Nvidia Investor Should Keep an Eye on This Number

Nvidia (NASDAQ: NVDA) has been one of the hottest stocks on the market for the past couple of years, up an absurd 610% since the start of 2023 (as of April 16). Nvidia’s historic run can be attributed to one thing: artificial intelligence (AI).

AI has taken the world by storm, and Nvidia is one of the most important companies powering the development because its graphic processing units (GPUs) are the go-to for training AI models. That’s why all Nvidia investors need to keep an eye on the company’s data center revenue. It’s directly tied to its AI dominance and growth potential.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

NVDA Revenue (Quarterly) Chart

NVDA Revenue (Quarterly) data by YCharts

Data center revenue, which includes GPUs and other relevant hardware, is now Nvidia’s largest business segment. In the fourth quarter of its fiscal year 2025, Nvidia’s data center revenue grew 93% year over year to $35.6 billion (over 90% of total revenue).

Nvidia investors shouldn’t expect data revenue to keep growing at 90%+ quarter after quarter, but any huge drops in growth could be a red flag that demand for AI infrastructure is falling or Nvidia is losing market share to competitors like Advanced Micro Devices. However, given Nvidia’s market dominance, it would likely be the former.

Much of Nvidia’s valuation is built on high investor expectations of AI-driven growth and continued dominance in the data center market. Any signs of noticeable demand decline could cause investors to jump ship and the stock to become extra volatile (or more volatile than it already has been).

See also  <!DOCTYPE html><html><head> <title>Navigating the September Stock Market Blues with Medical Stocks</title></head><body><h2>Understanding the September Stock Market Trends</h2><p>Historically, September has proven to be a tumultuous month for stock investors. Dubbed the September Effect, this phenomenon is characterized by increased market volatility and lower overall stock performance, often influenced by economic policy decisions and higher trading volumes post-summer.</p><h2>Why Medical Stocks Might Be Your Best Bet</h2><p>During seasons of heightened market uncertainty, many investors turn to defensive sectors such as healthcare for stability and protection against market downturns. As the demand for essential services remains consistent, medical stocks are often viewed as a safe haven amid the September storm.</p><h2>DaVita: A Strong Contender</h2><p>DaVita, a leading provider of dialysis services, has been turning heads with its impressive stock performance, soaring over 40% year-to-date. With a Zacks Rank #1 (Strong Buy) and attractive valuation metrics, DaVita seems well-positioned to weather the storm of September. Analysts predict steady revenue growth for the company in the upcoming fiscal years, adding to its appeal for investors seeking stability.</p><h2>HCA Healthcare: Riding the Wave</h2><p>Another top player in the medical stocks arena is HCA Healthcare, the largest operator of non-governmental acute care hospitals in the US. With a Zacks Rank #1 (Strong Buy) and a robust earnings outlook, HCA Healthcare has seen its stock price climb over 40% this year. The company's focus on value and consistent revenue expansion make it a compelling choice for investors looking for solid returns.</p><h2>Eli Lilly: Innovating for Success</h2><p>Eli Lilly has been making waves in the pharmaceutical industry with its innovative drug pipeline catering to the needs of Type 2 diabetics. With a Zacks Rank #2 (Buy) and a strong market presence in the diabetes and obesity treatment space, Eli Lilly is well-positioned for growth in the coming years. The company's aggressive growth projections and positive sentiment around its products make it a promising option for investors seeking exposure to the healthcare sector.</p><h2>Looking Ahead</h2><p>As investors brace themselves for the uncertainties of September, the allure of medical stocks shines bright. With companies like DaVita, HCA Healthcare, and Eli Lilly displaying resilience and growth potential, these stocks may serve as anchors in an otherwise turbulent market. Keeping a keen eye on market trends and leveraging the stability of healthcare stocks could be the winning strategy for navigating the September Effect.</p></body></html><!DOCTYPE html><html><head> <title>Exploring Top Medical Stocks Amid Market Volatility</title></head><body> Unveiling Top Medical Stocks Amid Market Uncertainty

Paying attention to Nvidia’s data center revenue can help investors gauge whether the AI boom is progressing, becoming stagnant, or fading. In either case, that could affect Nvidia’s value proposition to investors.

Should you invest $1,000 in Nvidia right now?

Before you buy stock in Nvidia, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $524,747!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $622,041!*

Now, it’s worth noting Stock Advisor’s total average return is 792% — a market-crushing outperformance compared to 153% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of April 14, 2025

Stefon Walters has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices and Nvidia. The Motley Fool has a disclosure policy.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.